Comparison of topical keturolac versus dexamethasone after vitreo-retinal surgery
| ISRCTN | ISRCTN79787764 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN79787764 |
| Secondary identifying numbers | N0287023319 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 31/03/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Douglas Newman
Scientific
Scientific
Box No 41
Department of Ophthalmology
Addenbrooke's NHS Trust
Cambridge
CB2 2QQ
United Kingdom
| Phone | +44 (0)1223 245151 (x 2701) |
|---|---|
| abc@email.com |
Study information
| Study design | Prospective randomised double-blind study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Scientific title | Comparison of topical keturolac versus dexamethasone after vitreo-retinal surgery |
| Study objectives | The aim of the study is to determine if topical ketorulac has equal anti-inflammatory efficacy to dexamethasone with fewer adverse effects (specifically steroid-induced glaucoma). |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Surgery: Vitreo-retinal |
| Intervention | Prospective, randomised, double blind study comparing topical keturolac to dexamethasone as post-operative anti-inflammatory medication following vitreo-retinal surgery. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Keturolac, dexamethasone |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 02/04/1998 |
| Completion date | 19/06/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 02/04/1998 |
| Date of final enrolment | 19/06/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Addenbrooke's NHS Trust
Cambridge
CB2 2QQ
United Kingdom
CB2 2QQ
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Hospital/treatment centre
Cambridge Consortium - Addenbrooke's (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
31/03/2020: No publications found, all search options exhausted, study status unverified.
